alexa Abstract | Extending Life: From Stem Cells to Gene Therapy
ISSN: 2472-128X

Journal of Clinical & Medical Genomics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access


This paper deals with stem cell boogies and longevity market on the DNA gene therapy business. In Dr. James Canton’s book, The Extreme Future, the author mentions several health cures and enhancement ideas that stem- cell treatments may offer in twenty years: 1) New organs, including hearts and lungs; 2) New bone growth for legs, arms, and backs; 3) New sensory functions and optic nerves to restore eyesight; 4) New cancer treatments; 5) New nerves to heal muscles and to restore movement; 6) New cells to offset the aging brain. Since, James Watson and Francis Crick discovered and published the book The Double Helix (1968), DNA; the health sciences have had an incredible boom and growth. DNA is the basics of life’s inheritance, and most of the modern health innovations are due to its understanding. “Life-extension treatments, from genetic vaccines and designer DNA ‘surgery’ to smart drugs and neuro-medical devices, will augment health, improving intelligence, and maximizing beauty” [1]. A clear picture of what is ahead is also given also by James Martin a rocket scientist in his book: The Meaning of the 21st Century, on gene therapy or “genetically modified humans,” as well as shedding light on our other topic of “the magic of stem cells.” This report is written for Departmental Heads of the Institute of Public Health (IPH) in Albania, who are in position of developing future healthcare policies, and supporting development programs of “adult stem cells” and “genetic engineering” cures for population at large. The interested investors will be the healthcare insurance companies, public health officials, and tertiary hospital caregivers in the healthcare industry, which will join in a Public-Private-Partnership (PPP) to achieve the desired results to cure damaged tissues of the human body and heal genetically inherited disease by gene splicing and insertion, also known as transplanting genes

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Judson Gary and Genard Hajdini


Stem cells,Gene Therapy, Life, DNA, Genetic Diseases, Genomic Sequencing

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version